Swissray to divest Empower as part of restructuring effort

Article

Swissray to divest Empower as part of restructuring effortDigital radiography developer Swissray International last month announced that it has signed a letter of intent to sell its Swissray Empower U.S. film and x-ray accessories division, a

Swissray to divest Empower as part of restructuring effort

Digital radiography developer Swissray International last month announced that it has signed a letter of intent to sell its Swissray Empower U.S. film and x-ray accessories division, a business it acquired less than a year ago. Swissray said it was making the move as part of a corporate reorganization designed to focus the company on digital imaging.

Swissray acquired Empower in April 1997 as part of the company's aggressive effort to offer a wide range of products and services to customers. The decision to divest Empower may be a sign that the company's plan may have been a bit ambitious, however. Swissray also has multivendor service and PACS subsidiaries, in addition to its conventional and digital x-ray manufacturing business (PNN 2/98).

Swissray will sell Empower to distributor E.M. Parker, based in Wilmington, MA. Terms of the transaction are still being negotiated, with a completion date expected during the current fiscal year, according to Swissray of New York City.

The company's board of directors has also announced that it has decided to restructure its senior management as part of a plan to grow Swissray beyond a developmental-stage company, said Ruedi Laupper, chairman. A search is under way for a new CEO and CFO. In the meantime, primary management responsibility will be held by a newly formed executive committee of the board of directors, consisting of Akbar Seddigh, Daniel Wuersch, and Dr. Erwin Zimmerli. Laupper, who previously also held the titles of president and CEO, retains primary responsibility for day-to-day operations.

The vendor is also reviewing its strategic focus, and is preparing a long-term business and financial plan so that the company can raise capital to successfully implement its strategy over the next two years. In an earlier release, Swissray disclosed that it planned to enter into immediate negotiations with a group of investors to finance the firm's short-term and medium-term capital needs.

In other Swissray news, the company has sold another AddOn-Multi-System to Dutchess Radiology Associates, of Poughkeepsie, NY. Financial terms of the sale were not disclosed.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.